Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adelaide A Hebert

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsThomas Luger, Mark Boguniewicz, Warner Carr, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension TrialEric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Pediatric Dermatology|March 31, 2018
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industryElaine C Siegfried, Jennifer C Jaworski, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneJohn J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patientsHeather A Brandling-Bennett, Lisa M Arkin, Yvonne E Chiu, et al.
Archives of Dermatological Research|December 1, 2022
The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Archives of Dermatological Research|December 3, 2022
Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic DermatologyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 6, 2015
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsThomas Luger, Mark Boguniewicz, Warner Carr, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 10, 2025
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension TrialEric L Simpson, Lawrence F Eichenfield, Kim A Papp, et al.
JAMA|September 20, 2022
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical TrialsMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Pediatric Dermatology|March 31, 2018
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industryElaine C Siegfried, Jennifer C Jaworski, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology|November 4, 2004
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneJohn J DiGiovanna, Craig B Langman, Eduardo H Tschen, et al.
Pediatric Dermatology|June 14, 2023
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelinesElaine C Siegfried, Lisa M Arkin, Yvonne E Chiu, et al.
Journal of the American Academy of Dermatology|February 11, 2024
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patientsHeather A Brandling-Bennett, Lisa M Arkin, Yvonne E Chiu, et al.
Archives of Dermatological Research|December 1, 2022
The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Archives of Dermatological Research|December 3, 2022
Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic DermatologyKira Minkis, Diana Bolotin, M Laurin Council, et al.
Pageof 15